Cardinal Health Inc. [CAH] is 3.38% higher this YTD. Is it still time to buy?

Cardinal Health Inc. [NYSE: CAH] plunged by -$1.03 during the normal trading session on Thursday and reaching a high of $52.98 during the day while it closed the day at $52.29. The company report on November 12, 2020 that Cardinal Health Partners with CDC to Support Vaccine Access for Pharmacies.

Cardinal Health (NYSE: CAH) has reached an agreement with the Centers for Disease Control and Prevention (CDC) to act as a network administrator in Phase 2 of the Federal Pharmacy Partnership Strategy for COVID-19, which will enable retail independent, small chains and long-term care pharmacy customers to participate in the vaccination effort. The COVID-19 vaccine will be distributed by the CDC’s central distributor.

“Cardinal Health is committed to working with the CDC and our pharmacy customers to ensure a safe and secure COVID-19 vaccine administration network across the United States. The breadth and expertise of Cardinal Health makes us a vital partner to help the country move forward,” said Victor Crawford, CEO Pharmaceutical Segment. “Pharmacists are serving on the front line of the national response to the COVID-19 pandemic and are an important part of our nation’s fight against the pandemic.”.

Cardinal Health Inc. stock has also loss -6.62% of its value over the past 7 days. However, CAH stock has inclined by 4.89% in the 3 months of the year. Over the past six months meanwhile, it has lost -2.43% and gained 3.38% year-on date.

The market cap for CAH stock reached $14.96 billion, with 293.00 million shares outstanding and 292.89 million shares in the current float. Compared to the average trading volume of 2.24M shares, CAH reached a trading volume of 2798259 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Cardinal Health Inc. [CAH]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CAH shares is $61.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CAH stock is a recommendation set at 2.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Barclays have made an estimate for Cardinal Health Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on November 02, 2020. The new note on the price target was released on September 25, 2020, representing the official price target for Cardinal Health Inc. stock. On May 15, 2020, analysts increased their price target for CAH shares from 48 to 64.

The Average True Range (ATR) for Cardinal Health Inc. is set at 2.01, with the Price to Sales ratio for CAH stock in the period of the last 12 months amounting to 0.10. The Price to Book ratio for the last quarter was 10.78, with the Price to Cash per share for the same quarter was set at 9.60. Price to Free Cash Flow for CAH in the course of the last twelve months was 7.74 with Quick ratio for the last quarter at 0.60.

CAH stock trade performance evaluation

Cardinal Health Inc. [CAH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.62. With this latest performance, CAH shares gained by 9.32% in over the last four-week period, additionally sinking by -2.43% over the last 6 months – not to mention a drop of -5.63% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CAH stock in for the last two-week period is set at 52.21, with the RSI for the last a single of trading hit 46.56, and the three-weeks RSI is set at 52.57 for Cardinal Health Inc. [CAH]. The present Moving Average for the last 50 days of trading for this stock 49.15, while it was recorded at 55.24 for the last single week of trading, and 51.19 for the last 200 days.

Cardinal Health Inc. [CAH]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Cardinal Health Inc. [CAH] shares currently have an operating margin of +1.16 and a Gross Margin at +4.15. Cardinal Health Inc.’s Net Margin is presently recorded at -2.42.

Return on Total Capital for CAH is now 15.24, given the latest momentum, and Return on Invested Capital for the company is -32.42. Return on Equity for this stock declined to -91.07, with Return on Assets sitting at -9.04. When it comes to the capital structure of this company, Cardinal Health Inc. [CAH] has a Total Debt to Total Equity ratio set at 403.58. Additionally, CAH Total Debt to Total Capital is recorded at 80.14, with Total Debt to Total Assets ending up at 17.71. Long-Term Debt to Equity for the company is recorded at 397.21, with the Long-Term Debt to Total Capital now at 78.88.

Reflecting on the efficiency of the workforce at the company, Cardinal Health Inc. [CAH] managed to generate an average of -$77,000 per employee. Receivables Turnover for the company is 18.27 with a Total Asset Turnover recorded at a value of 3.74.Cardinal Health Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.60 and a Current Ratio set at 1.10.

Earnings per share (EPS) analysis for Cardinal Health Inc. [CAH] stock

With the latest financial reports released by the company, Cardinal Health Inc. posted 1.52/share EPS, while the average EPS was predicted by analysts to be reported at 1.22/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 24.60%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CAH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Cardinal Health Inc. go to 5.08%.

Cardinal Health Inc. [CAH]: Insider Ownership positions

There are presently around $12,987 million, or 86.90% of CAH stock, in the hands of institutional investors. The top three institutional holders of CAH stocks are: VANGUARD GROUP INC with ownership of 35,856,449, which is approximately -0.967% of the company’s market cap and around 0.40% of the total institutional ownership; BLACKROCK INC., holding 25,084,361 shares of the stock with an approximate value of $1.31 billion in CAH stocks shares; and STATE STREET CORP, currently with $906.3 million in CAH stock with ownership of nearly -4.7% of the company’s market capitalization.

Positions in Cardinal Health Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 330 institutional holders increased their position in Cardinal Health Inc. [NYSE:CAH] by around 16,979,211 shares. Additionally, 389 investors decreased positions by around 20,645,303 shares, while 113 investors held positions by with 210,747,957 shares. The mentioned changes placed institutional holdings at 248,372,471 shares, according to the latest SEC report filing. CAH stock had 70 new institutional investments in for a total of 1,346,618 shares, while 88 institutional investors sold positions of 5,358,838 shares during the same period.

Share on facebook
Share on twitter
Share on linkedin
Share on skype
Share on reddit

Leave a Comment

Your email address will not be published. Required fields are marked *



Download Free eBook For


100% free. stop anytime no spam



Download Free eBook For


100% free. stop anytime no spam